# MUBD-DecoyMaker2.0

Introduction
-----------------------------------

MUBD-DecoyMaker2.0, an updated version of MUBD-DECOYMAKER, is a Python GUI application to generate maximal unbiased benchmarking sets data sets for virtual drug screening. It can be run on Windows-based machine and has no dependency. 

Availability & Implementation
-----------------------------------

* Due to the large size, the Python GUI application has been uploaded to the cloud drives and is accessible from there：
  https://www.dropbox.com/s/dfa35t2jb0fnarx/MUBD-DecoyMaker2.0.exe?dl=0     (Outside China) or
  https://pan.baidu.com/s/110FJY6YHxcaUmI7fSyUSkw  (China)


Documentation
-----------------------------------

* The manual for the Python GUI application and the files for the case study are available at this website, i.e. 'manual.for.MUBD-Decoymaker2.0.pdf' and 'Case-ACM4-Agonists.zip'.


Installation
-----------------------------------

* We recommend the users to run the Python GUI application on Windows-based machines, as all the dependencies have been included. Please note we used the machine with Intel Core(TM) i7-7700 CPU@3.60GHz and RAM of 16 GB for testing the tool. The computation time for the test case of ACM Agonists was 1882 seconds. 
 


References
-----------------------------------
Computational tool, Methodology and Datasets:
1. Xia, J., Li, S., Ding, Y., Wu, S. and Wang, X.S., MUBD‐DecoyMaker 2.0: A Python GUI Application to Generate Maximal Unbiased Benchmarking Data Sets for Virtual Drug Screening. Mol. Inf.,2020, 39, 1900151. 
https://doi.org/10.1002/minf.201900151 (Tool)
2. Xia, J.; Jin, H.; Liu, Z.; Zhang, L.; Wang, X.S., An unbiased method to build benchmarking sets for ligand-based virtual screening and its application to GPCRs. J. Chem. Inf. Model., 2014, 54 (5): 1433-1450. 
https://pubs.acs.org/doi/10.1021/ci500062f  (Algorithm and MUBD-GPCRs/ULS/UDS)
3. Xia, J.; Tilahun, E.L.; Kebede, E.H.; Reid, T.E.; Zhang, L.;Wang, X.S.,Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families. J. Chem. Inf. Model., 2015, 55 (2): 374-388. 
https://pubs.acs.org/doi/10.1021/ci5005515  (MUBD-HDACs)
4. Xia, J.; Reid, T.E.; Wu, S.; Zhang, L.; Wang, X.S., Maximal Unbiased Benchmarking Data Sets for Human Chemokine Receptors and Comparative Analysis. J. Chem. Inf. Model., 2018, 58 (5): 1104-1120. 
https://pubs.acs.org/doi/10.1021/acs.jcim.8b00004 (MUBD-hCRs)

Selected Applications of MUBD:

1. Dou, X.; Huang, H.; Li, Y.; Jiang, L.; Wang, Y.; Jin, H.; Jiao, N.; Zhang, L.; Zhang, L.; Liu, Z., Multistage Screening Reveals 3-Substituted Indolin-2-One Derivatives as Novel and Isoform-Selective C-Jun N-Terminal Kinase 3 (Jnk3) Inhibitors: Implications to Drug Discovery for Potential Treatment of Neurodegenerative Diseases. J. Med. Chem., 2019, 62, 6645-6664. 
https://doi.org/10.1021/acs.jmedchem.9b00537
2. Wang Y.; Dou X.; Jiang L.; Jin H.; Zhang L.; Zhang L.; Liu Z., Discovery of novel glycogen synthase kinase-3α inhibitors: Structure-based virtual screening, preliminary SAR and biological evaluation for treatment of acute myeloid leukemia. Eur. J. Med. Chem., 2019,171, 221-234.
https://doi.org/10.1016/j.ejmech.2019.03.039
3. Dou, X.; Jiang, L.; Wang, Y.; Jin, H.; Liu, Z.; Zhang, L., Discovery of New Gsk-3beta Inhibitors through Structure-Based Virtual Screening. Bioorg. Med. Chem. Lett., 2018, 28, 160-166.
https://doi.org/10.1016/j.bmcl.2017.11.036
4. Kong, Y.; Bender, A.; Yan, A., Identification of Novel Aurora Kinase a (Aurka) Inhibitors Via Hierarchical Ligand-Based Virtual Screening. J. Chem. Inf. Model., 2018, 58, 36-47.
 https://doi.org/10.1021/acs.jcim.7b00300
 5. Huo, D.; Wang, S.; Kong, Y.; Qin, Z.; Yan, A., Discovery of Novel Epidermal Growth Factor Receptor (EGFR) Inhibitors Using Computational Approaches. J. Chem. Inf. Model., 2021.
 https://doi.org/10.1021/acs.jcim.1c00884
 6. Sedykh, A. Y.; Shah, R. R.; Kleinstreuer, N. C.; Auerbach, S. S.; Gombar, V. K., Saagar–A New, Extensible Set of Molecular Substructures for QSAR/QSPR and Read-Across Predictions. Chem. Res. Toxicol. 2021, 34 (2), 634-640. 
 https://doi.org/10.1021/acs.chemrestox.0c00464
 7. Zhou, H.; Cao, H.; Skolnick, J., FINDSITEcomb2.0: A New Approach for Virtual Ligand Screening of Proteins and Virtual Target Screening of Biomolecules. J. Chem. Inf. Model. 2018, 58 (11), 2343-2354. 
 https://doi.org/10.1021/acs.jcim.8b00309
 8. Pei, F., Jin, H., Zhou, X., Xia, J., Sun, L., Liu, Z. and Zhang, L. (2015), Enrichment Assessment of Multiple Virtual Screening Strategies for Toll-Like Receptor 8 Agonists Based on a Maximal Unbiased Benchmarking Data Set. Chem Biol Drug Des, 86: 1226-1241. 
 https://doi.org/10.1111/cbdd.12590
